Ceribell point-of-care AI EEG versus conventional EEG: multicenter retrospective outcomes study in Neurocritical Care

Summary

A multicenter retrospective study published in Neurocritical Care compared outcomes in ICU patients evaluated with Ceribell point-of-care AI EEG versus those evaluated with conventional EEG. Ceribell use was associated with significant reduction in length of ICU stay, fewer patients discharged with poor functional disability scores (modified Rankin Scale), and substantially faster door-to-EEG time. The study spans multiple academic and community hospital sites, providing evidence for Ceribell's real-world clinical impact beyond the academic settings where conventional EEG monitoring is most available.